Effects of rosiglitazone and sulphonylureas on ischaemic burden, blood pressure and novel risk markers inclusive of vascular function in patients with chronic stable angina and type 2 diabetes mellitus: a randomised, double-blinded study

Trial Profile

Effects of rosiglitazone and sulphonylureas on ischaemic burden, blood pressure and novel risk markers inclusive of vascular function in patients with chronic stable angina and type 2 diabetes mellitus: a randomised, double-blinded study

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 07 Sep 2006

At a glance

  • Drugs Gliclazide; Rosiglitazone
  • Indications Angina pectoris; Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 05 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top